Position in HLN
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$3,578,540
-$220,425 QoQ
Shares Held
383,552
+1.1% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#86
of 639 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026QRG CAPITAL MANAGEMENT, INC. holds $23,691,979 across 10 Drug Manufacturers - Specialty & Generic names. HLN ranks #3 (15.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
|
372,752 | $5,975,214 | |
| 2 | ZTS |
Zoetis Inc.
|
54,575 | $3,921,759 | |
| 3 | HLN |
Haleon plc
This page
|
383,552 | $3,578,540 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
18,903 | $3,185,911 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
89,078 | $3,017,962 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
3,476 | $1,883,401 | |
| 7 | VTRS |
Viatris Inc
|
49,564 | $787,076 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
41,233 | $597,466 |
All Filings in HLN
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,578,540 | 383,552 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $3,798,965 | 379,517 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $3,267,097 | 323,155 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $2,626,218 | 292,778 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $5,321,489 | 513,162 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $4,650,750 | 451,968 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $3,113,436 | 326,356 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $2,136,461 | 201,934 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $1,379,833 | 167,050 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $1,260,731 | 148,496 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $1,131,814 | 137,523 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $619,910 | 74,419 | Shares | Sole | 2023-11-13 | |
| No filing history on record for this holder in this stock. | ||||||